Vanda

EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
3 Small-Cap Biotechs That Institutions Are Loving
Yahoo/Benzinga
Mon, 07/7/14 - 07:30 pm
Infinity Pharmaceuticals
Vanda
Lexicon Pharmaceuticals
Tuesday’s Top Biotech Stories: Vanda Pharmaceuticals, Prosensa, and Clovis Oncology
Motley Fool
Tue, 06/3/14 - 11:38 am
Vanda
Prosensa
Clovis Oncology
Hetlioz
CO-1686
drisapersen
Vanda Pharmaceuticals Wins FDA Approval of Sleep Disorder Drug
Wall St Cheat Sheet
Sat, 02/1/14 - 10:44 am
Hetlioz
Vanda
sleep aid
hypnotics
Will the FDA Approve Vanda's Hetlioz?
Motley Fool
Tue, 01/28/14 - 11:54 am
Vanda
FDA
Hetlioz
non-24 hour disorder
2014 Biotechnology Catalysts
Seeking Alpha
Fri, 01/10/14 - 08:14 am
Chelsea Therapeutics
Durect Corporation
EXACT Sciences
Vanda
Pozen
Progenics
MannKind
FDA
22 Biotech Stock Predictions for 2014
TheStreet.com
Mon, 01/6/14 - 09:47 am
biotech
Vertex Pharmaceuticals
Orexigen
Retrophin
Valeant Pharmaceuticals
Questcor
Biomarin
Merck
NeoStem
Amgen
Gilead Sciences
Vanda
Keryx
Peregrine Pharmaceuticals
CelSci
Regeneron
Cempra
Dendreon
Clovis Oncology
Halozyme
NPS Pharmaceuticals
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Biotech Stock Roundup: Vanda Soars, Sarepta Slumps
Yahoo/Zacks.com
Wed, 11/20/13 - 11:47 am
Vanda
Sarepta Therapeutics
tasimelteon
Hetlioz
Duchenne Muscular Dystrophy
eteplirsen
Amarin, Sarepta And Vanda: Teachable Moments In Biotech
Seeking Alpha
Sun, 11/17/13 - 12:13 pm
Amarin
Sarepta
Vanda
This Week in Biotech
Motley Fool
Sat, 11/16/13 - 01:23 pm
Vanda
Cadence Pharmaceuticals
Immunogen
Novartis
Pharmacyclics
JNJ
Epizyme
Sarepta Therapeutics
GSK
U.S. FDA panel backs Vanda's circadian rhythm drug
Yahoo/Reuters
Thu, 11/14/13 - 05:50 pm
FDA
advisory panels
Vanda
non-24 hour disorder
tasimelteon
Vanda Pharma FDA Panel Live Blog
TheStreet.com
Thu, 11/14/13 - 08:53 am
Vanda
FDA
advisory panels
tasimelteon
non-24 hour disorder
blindness
FDA reviewer recommends approval of Vanda sleep drug for blind
The Fly on the Wall
Tue, 11/12/13 - 08:52 am
FDA
Vanda
non-24 hour disorder
tasimelteon
Upcoming Catalysts Should Provide Strong Upside For These BioPharma Companies
Seeking Alpha
Fri, 10/18/13 - 10:51 am
Celldex
ImmunoCellular Therapeutics
Enanta
Merrimack Pharmaceuticals
Vanda
More Trouble For Vanda's Sleep Disorder Drug
TheStreet.com
Wed, 08/7/13 - 09:47 am
Vanda
tasimelteon
non-24 hour disorder
Vanda Pharmaceuticals Reports Second Quarter 2013 Results
Yahoo/PR Newswire
Wed, 07/31/13 - 09:13 am
Vanda
earnings
Vanda says Phase III study data shows cortisol rhythm restoration
Yahoo/Fly on the Wall
Tue, 06/18/13 - 09:52 am
Vanda
cortisol
tasimelteon
non-24 hour disorder
Vanda files for approval of sleep disorder drug
Yahoo/AP
Fri, 05/31/13 - 01:01 pm
Vanda
tasimelteon
Why Did Vanda Pharmaceuticals Hit A 52-Week High?
Seeking Alpha
Fri, 04/19/13 - 08:49 am
Vanda
Sanofi
Novartis
Eli Lilly
tasimelteon
Fanapt

Pages